GLYCOCINS: The sugar peppered antimicrobials

Area of Science:

• Bacterial glycobiology
• Antimicrobial peptide research
• Biotechnology

Background:

• Glycocins, or glycosylated bacteriocins, are bioactive peptides produced by bacteria for survival, first identified in 2011.
• These molecules feature diverse glycan structures, including rare S-linked glycans, and exhibit significant antimicrobial activity.
• Over 250 glycocins have been identified in silico, complementing the 13 experimentally characterized ones.

Purpose of the Study:

• To review the roles of characterized glycocins and their associated glycosyltransferases (GTs).
• To explore the structure-function relationships of glycans in mediating antibacterial activity.
• To discuss emerging strategies for utilizing bacterial glycobiology in food preservation and antibiotic development.

Main Methods:

• Literature review focusing on characterized glycocins and their biosynthesis pathways.
• Analysis of glycan structures and their impact on antimicrobial efficacy.
• Exploration of glycoengineering and heterologous expression for glycopeptide production.

Main Results:

• Glycocins demonstrate efficacy against drug-resistant and foodborne pathogens.
• Glycosyltransferases involved in glycocin biosynthesis often form gene clusters, facilitating glycoengineering.
• Heterologous expression enables the creation of microbial factories for glycopeptide and glycoconjugate production.

Conclusions:

• Glycocins represent a promising class of antimicrobials due to their glycan-mediated activity.
• Bacterial glycobiology offers innovative approaches for developing novel food preservatives and alternatives to conventional antibiotics.
• Targeted glycoengineering of glycocins holds potential for industrial applications in glycopeptide and glycoconjugate synthesis.